FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109557274> ?p ?o ?g. }

• W2109557274 endingPage "241" @default.
• W2109557274 startingPage "233" @default.
• W2109557274 abstract "We investigated the prevalence of prior myocardial infarction (MI) and incidence of ischaemic cardiovascular (CV) events among atrial fibrillation (AF) patients. In ROCKET AF, 14 264 patients with nonvalvular AF were randomized to rivaroxaban or warfarin. The key efficacy outcome for these analyses was CV death, MI, and unstable angina (UA). This pre-specified analysis was performed on patients while on treatment. Rates are per 100 patient-years. Overall, 2468 (17%) patients had prior MI at enrollment. Compared with patients without prior MI, these patients were more likely to be male (75 vs. 57%), on aspirin at baseline (47 vs. 34%), have prior congestive heart failure (78 vs. 59%), diabetes (47 vs. 39%), hypertension (94 vs. 90%), higher mean CHADS2 score (3.64 vs. 3.43), and fewer prior strokes or transient ischaemic attacks (46 vs. 54%). CV death, MI, or UA rates tended to be lower in patients assigned rivaroxaban compared with warfarin [2.70 vs. 3.15; hazard ratio (HR) 0.86, 95% confidence interval (CI) 0.73–1.00; P = 0.0509]. CV death, MI, or UA rates were higher in those with prior MI compared with no prior MI (6.68 vs. 2.19; HR 3.04, 95% CI 2.59–3.56) with consistent results for CV death, MI, or UA for rivaroxaban compared with warfarin in prior MI compared with no prior MI (P interaction = 0.10). Prior MI was common and associated with substantial risk for subsequent cardiac events. Patients with prior MI assigned rivaroxaban compared with warfarin had a non-significant 14% reduction of ischaemic cardiac events." @default.
• W2109557274 created "2016-06-24" @default.
• W2109557274 creator A5004956623 @default.
• W2109557274 creator A5014777482 @default.
• W2109557274 creator A5014800121 @default.
• W2109557274 creator A5020290782 @default.
• W2109557274 creator A5023346746 @default.
• W2109557274 creator A5036147033 @default.
• W2109557274 creator A5039432822 @default.
• W2109557274 creator A5039466154 @default.
• W2109557274 creator A5047187243 @default.
• W2109557274 creator A5049537975 @default.
• W2109557274 creator A5060254903 @default.
• W2109557274 creator A5060829829 @default.
• W2109557274 creator A5062843291 @default.
• W2109557274 creator A5083697264 @default.
• W2109557274 creator A5086040903 @default.
• W2109557274 date "2013-10-15" @default.
• W2109557274 modified "2023-09-25" @default.
• W2109557274 title "Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial" @default.
• W2109557274 cites W1975757685 @default.
• W2109557274 cites W1981294902 @default.
• W2109557274 cites W1998083759 @default.
• W2109557274 cites W2000338500 @default.
• W2109557274 cites W2007222955 @default.
• W2109557274 cites W2011680582 @default.
• W2109557274 cites W2025557370 @default.
• W2109557274 cites W2039904107 @default.
• W2109557274 cites W2057308876 @default.
• W2109557274 cites W2086061415 @default.
• W2109557274 cites W2093754506 @default.
• W2109557274 cites W2096606175 @default.
• W2109557274 cites W2097854437 @default.
• W2109557274 cites W2104893203 @default.
• W2109557274 cites W2108064339 @default.
• W2109557274 cites W2108659563 @default.
• W2109557274 cites W2108855833 @default.
• W2109557274 cites W2112505092 @default.
• W2109557274 cites W2112841595 @default.
• W2109557274 cites W2117677020 @default.
• W2109557274 cites W2127090290 @default.
• W2109557274 cites W2136489990 @default.
• W2109557274 cites W2141889414 @default.
• W2109557274 cites W2151074096 @default.
• W2109557274 cites W2157718162 @default.
• W2109557274 cites W2159370853 @default.
• W2109557274 cites W2161876144 @default.
• W2109557274 cites W2162508946 @default.
• W2109557274 cites W2164861810 @default.
• W2109557274 cites W2165626532 @default.
• W2109557274 cites W2546697497 @default.
• W2109557274 cites W3388698 @default.
• W2109557274 cites W4292280632 @default.
• W2109557274 cites W59237391 @default.
• W2109557274 doi "https://doi.org/10.1093/eurheartj/eht428" @default.
• W2109557274 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3896862" @default.
• W2109557274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24132190" @default.
• W2109557274 hasPublicationYear "2013" @default.
• W2109557274 type Work @default.
• W2109557274 sameAs 2109557274 @default.
• W2109557274 citedByCount "75" @default.
• W2109557274 countsByYear W21095572742013 @default.
• W2109557274 countsByYear W21095572742014 @default.
• W2109557274 countsByYear W21095572742015 @default.
• W2109557274 countsByYear W21095572742016 @default.
• W2109557274 countsByYear W21095572742017 @default.
• W2109557274 countsByYear W21095572742018 @default.
• W2109557274 countsByYear W21095572742019 @default.
• W2109557274 countsByYear W21095572742020 @default.
• W2109557274 countsByYear W21095572742021 @default.
• W2109557274 countsByYear W21095572742022 @default.
• W2109557274 countsByYear W21095572742023 @default.
• W2109557274 crossrefType "journal-article" @default.
• W2109557274 hasAuthorship W2109557274A5004956623 @default.
• W2109557274 hasAuthorship W2109557274A5014777482 @default.
• W2109557274 hasAuthorship W2109557274A5014800121 @default.
• W2109557274 hasAuthorship W2109557274A5020290782 @default.
• W2109557274 hasAuthorship W2109557274A5023346746 @default.
• W2109557274 hasAuthorship W2109557274A5036147033 @default.
• W2109557274 hasAuthorship W2109557274A5039432822 @default.
• W2109557274 hasAuthorship W2109557274A5039466154 @default.
• W2109557274 hasAuthorship W2109557274A5047187243 @default.
• W2109557274 hasAuthorship W2109557274A5049537975 @default.
• W2109557274 hasAuthorship W2109557274A5060254903 @default.
• W2109557274 hasAuthorship W2109557274A5060829829 @default.
• W2109557274 hasAuthorship W2109557274A5062843291 @default.
• W2109557274 hasAuthorship W2109557274A5083697264 @default.
• W2109557274 hasAuthorship W2109557274A5086040903 @default.
• W2109557274 hasBestOaLocation W21095572741 @default.
• W2109557274 hasConcept C126322002 @default.
• W2109557274 hasConcept C164705383 @default.
• W2109557274 hasConcept C207103383 @default.
• W2109557274 hasConcept C2776301958 @default.
• W2109557274 hasConcept C2777628954 @default.
• W2109557274 hasConcept C2777785093 @default.
• W2109557274 hasConcept C2778198053 @default.
• W2109557274 hasConcept C2778661090 @default.
• W2109557274 hasConcept C2779161974 @default.

• next